Blueprint Medicines
BPMC
$106.79
Share price
1.26%
Change (1 day)
93.67%
Change (1 year)
Categories
Market capitalization of Blueprint Medicines (BPMC)
Market cap: $6.85 Billion
As of May 2024 Blueprint Medicines has a market cap of $6.85 Billion. This makes Blueprint Medicines the world's 2190th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Blueprint Medicines from 2015 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $6.85 B | 22.18% |
| 2023 | $5.60 B | 113.92% |
| 2022 | $2.62 B | -58.41% |
| 2021 | $6.30 B | 0.83% |
| 2020 | $6.25 B | 58.35% |
| 2019 | $3.94 B | 66.27% |
| 2018 | $2.37 B | -27.57% |
| 2017 | $3.27 B | 253.25% |
| 2016 | $0.92 B | 30.15% |
| 2015 | $0.71 B |
End of Day market cap according to different sources
On May 14th, 2024 the market cap of Blueprint Medicines was reported to be:
$6.60 Billion
$6.60 Billion
$6.60 Billion
$6.45 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pacific Biosciences
PACB | $0.58 B | -91.47% | 🇺🇸 USA |
 OPKO Health
OPK | $0.94 B | -86.27% | 🇺🇸 USA |
 Acceleron Pharma XLRN | $10.93 B | 59.56% | 🇺🇸 USA |
 Isoray
ISR | $0.10 B | -98.44% | 🇺🇸 USA |